ERBB2 and breast carcinoma: For example, CAFs derived from human epidermal growth factor receptor 2 (HER2+) breast cancers have increased expression of pathways associated with integrin signaling and the actin cytoskeleton, which may contribute to the fibroblast-driven collective invasion of cancer cells [34, 35].